"Assignment of an HCPCS A‑code is an important step in supporting appropriate billing for Microlyte ® PainGuard™," said Terry ...
FRAMINGHAM, Mass., April 05, 2023 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical ...
FRAMINGHAM, Mass., Dec. 05, 2022 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical ...
The July 1 quarterly HCPCS Level II update includes several drug/biological code changes, according to an AAPC release. Effective July 1, the HCPCS Level II code J7184 will be replaced with Q2041 ...
Code assignment supports billing clarity and claims reporting for Imbed's synthetic antimicrobial wound matrix with localized, non-opioid pain management MIDDLETON, Wis., April 1, 2026 /PRNewswire/ -- ...
FRAMINGHAM, Mass., April 05, 2023 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“ Arch ” or the“ Company ”), a marketer and developer of novel self-assembling wound care and biosurgical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results